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Introduction
The eye is a unique organ comprising many different types of 
tissue. It is often involved in systemic disease. Patients with 
systemic disease may first present with eye pathology, and 
patients with known systemic illnesses may need to have 
their eyes specifically checked for ocular complications. It 
is thus useful for the physician to be familiar with the ocular 
manifestations of systemic diseases at primary care level. 
The need for an update in this field became apparent after 
a recent study on the primary health eye care knowledge 
of general practitioners.1 This article is the fourth in a series 
which attempts to address this issue. 
Approach to the patient
Knowledge of possible eye complications of common 
systemic diseases will dictate the direction which the eye 
assessment should take, and the part of the eye on which 
the examination should focus. Conversely, being familiar 
with the presenting eye symptoms of certain systemic 
diseases will facilitate diagnosis, possibly at an earlier stage 
than would otherwise occur. The diseases to be covered 
in this article and their ocular manifestations are listed in 
Table I.
Certain potentially life-threatening systemic illnesses 
have eye signs which may manifest before other common 
findings. The more common ones are listed in Table II.
Many systemic drugs cause ocular side-effects, while some 
ocular drugs have systemic side-effects. Familiarity with 
these can prevent unnecessary complications (Table III). 




Diabetic retinopathy is the cause of blindness in 
approximately 2.5-million of the estimated 50-million blind 
people in the world. The vision 2020 protocol projects 
diabetic retinopathy and glaucoma to be the “emerging” 
causes of blindness in developing countries. Loss of vision 
in diabetes is most commonly caused by cataracts, vitreous 
haemorrhage, maculopathy, tractional retinal detachment or 
neovascular glaucoma.3
Risk factors for the development of diabetic retinopathy 
include:4
•	 The duration of diabetes: The most important factor. 
Duration of disease is the strongest predictor of 
proliferative diabetic retinopathy.
•	 Poor control of diabetes: Tight blood glucose control, 
particularly when instituted early, can prevent or delay 
development of, or progression to, diabetic retinopathy.
•	 Pregnancy: Sometimes associated with rapid pro-
gression of diabetic retinopathy. Predicating factors 
include greater pre-pregnancy severity of retinopathy, 
poor pre-pregnancy control of diabetes, control exerted 
too rapidly during the early stages of pregnancy, and the 
development of pre-eclampsia and fluid imbalance. 
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Abstract
The eye is a unique organ which is often involved in systemic disease. Patients with systemic disease may first present 
with eye pathology, and patients with known systemic illnesses may need to have their eyes specifically checked for ocular 
complications. It is thus useful for the physician to be familiar with the ocular manifestations of common systemic diseases 
at primary care level. Diseases like diabetes, herpes zoster ophthalmicus and thyroid ophthalmopathy often involve the 
eyes, and if the eye signs are not identified early, the visual consequences can be devastating. Diabetic retinopathy is an 
important cause of blindness in this country. These, as well as common ocular manifestations of human immunodeficiency 
virus/acquired immune deficiency syndrome, syphilis, some dermatological conditions and the ocular side-effects of certain 
drugs, are discussed in this article. It is important for the primary care physician to be familiar with the spectrum of ocular 
involvement in systemic diseases since appropriate intervention and referral can be sight saving for the patient.
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•	 Hypertension: Tight control (blood pressure < 140/80 mmHg) 
is particularly beneficial in patients with type 2 diabetes with 
maculopathy.
•	 Nephropathy: If severe, is associated with worsening of 
diabetic retinopathy.
Screening for retinopathy in patients with diabetes should 
take place at puberty in type 1 (juvenile onset) as diabetic 
retinopathy rarely occurs before then, and at diagnosis 
for type 2 (adult onset). Fundoscopy (after pupil dilation) 
should be performed to detect microaneurysms, retinal 
haemorrhages (blot or flame-shaped), hard exudates, cotton 
wool spots, changes in the calibre of the retinal veins and 
new vessel formation. The classification of retinopathy and 
primary care management is illustrated in Figure 1, while 
some of the clinical findings can be visualised in Figures 2, 
3 and 4.
The treatment of diabetic retinopathy requires a 
multidisciplinary approach. Good glycaemic control should 
be emphasised. Laser photocoagulation is applied to 
oedematous areas in diabetic maculopathy (to stop blood 
vessel leakage), and to ischaemic areas in proliferative 
diabetic retinopathy, in order to decrease the oxygen 
demand of the hypoxic retina because of thermal damage 
to it (Figure 5). Complications of proliferative changes 
include vitreous haemorrhage (Figure 6) from the friable new 
vessels on the retina or disc, and neovascular glaucoma 
from the new vessels on the iris growing into the angle and 
tractional retinal detachment. Retinal surgery is required 
for nonresolving vitreous haemorrhage and advanced 
proliferative retinopathy, e.g. traction threatening the macula 
(Figure 7).5 New adjunctive therapies in the management of 
diabetic retinopathy, especially maculopathy, include steroid 
and antivascular endothelial growth factor agents, both 
injected into the vitreous cavity. These agents target the 
inflammatory and neovascular pathways that are involved 
in the formation of macular oedema and neovascularisation. 
Patients with diabetes are also at increased risk of other 
complications occurring elsewhere, but manifesting with 
ocular symptoms. Cranial nerve palsies may occur in 
patients with diabetes. Oculomotor (third) nerve palsy is the 
most common. It is the result of a microvasculopathy which 
involves the inner nerve fibres and spares the outer pupillary 
fibres. If it is complete and the pupil is spared, the patient 
Table I: The more common systemic diseases with ocular involvement
Disease More common ocular 
manifestations
Diabetes Retinopathy, and third and sixth 
nerve palsies
HIV/AIDS Herpes zoster ophthalmicus, 
microangiopathy, CMV retinitis, 
squamous cell carcinoma of 
conjunctiva and cranial nerve 
palsies
Thyroid eye disease Proptosis, optic neuropathy, lid 
retraction, restrictive myopathies 
and soft tissue swelling
Syphilis Uveitis, chorioretinitis and optic 
atrophy
Rheumatoid arthritis, SLE and 
other collagen vascular diseases
Scleritis, episcleritis and keratitis
Ankylosing spondylitis, psoriasis 
and other seronegative 
spondyloarthropathies
Uveitis
Eczema Keratoconjunctivitis, cataracts 
and keratoconus
AIDS: acquired immune deficiency syndrome, CMV: cytomegalovirus, HIV: human 
immunodeficiency virus, SLE: systemic lupus erythematosus
Table II: Systemic diseases, where eye findings may help in making 
the diagnosis2
Disease Ocular presentation
Myaesthenia gravis Ptosis and diplopia
Hyperlipidaemia Xanthelasma, arcus cornealis 
and presenile cataract
Marfan’s syndrome Myopia, dislocated lens and 
retinal detachment
Haematological disease, e.g. 
anaemia
Retinal haemorrhages, Roth 
spots and cotton wool spots 
Leukaemia and lymphoma Uveitis, retinitis, optic nerve 
infiltration and orbital disease
Malignant hypertension Disc swelling, retinal 
haemorrhages, hard exudates 
and cotton wool spots
Albinism Myopia, astigmatism and 
nystagmus
Neurofibromatosis (type 1) Eyelid neurofibromas and Lisch 
nodules on the iris
von Hippel-Lindau disease Retinal capillary haemangioma
Table III: Drugs and the eye2
Systemic drugs Ocular side-effects
Corticosteroids Cataracts, glaucoma, and 
worsening of herpetic keratitis
Ethambutol, isoniazid and 
streptomycin 
(anti-tuberculosis)
Toxic optic neuropathy, with loss 
of central and colour vision
Chloroquine Maculopathy, with loss of vision
Adrenaline and pseudoephedrine 
(in cold remedies), 
anticholinergics, antihistamines 
and atropine
Acute-angle closure glaucoma in 
susceptible individuals
Amiodarone Vortex keratopathy (innocuous 
corneal deposits)
Digoxin Xanthopsia (yellow vision)
Cidofovir and rifabutin (for HIV) Uveitis
Ocular drugs Systemic side-effects
Beta blockers (drops) Fatigue and impotence. 
Generally contraindicated in 
patients with asthma, heart block 
and peripheral vascular disease
Acetazolamide (Diamox® tablets) Lassitude, paraesthesiae, 
dyspepsia, renal stones and 
impotence
Alpha agonists (drops) Drowsiness, and apnoea (in 
neonates)
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should be followed-up regularly for 6-12 weeks, while 
watching for resolution. If the pupil is involved, compression 
by an aneurysm or tumour is most likely, and urgent referral 
for neuroimaging and evaluation by a neurosurgeon is 
indicated.
Mucormycosis is a rare opportunistic infection caused 
by fungi which typically affects patients with diabetic 
ketoacidosis, and is aggressive and often fatal. It involves 
the sinuses and subsequently spreads to the orbit and brain. 
These patients require aggressive in-hospital management.
Human immunodeficiency virus
Herpes zoster ophthalmicus 
The varicella zoster virus causes both chicken pox and 
herpes zoster (shingles). Mechanisms of ocular infection 
include: 
•	 Direct viral invasion, which may lead to conjunctivitis and 
epithelial keratitis.
•	 Secondary inflammation, which may cause episcleritis, 
scleritis, keratitis, uveitis, optic neuritis and cranial nerve 
palsies. Inflammation of the eyelid skin and conjunctiva 
can heal with severe scarring, resulting in a dry ocular 
surface.
Diabetic retinopathy
Review in six months 
for moderate, and in 12 
months for mild, NPDR
Refer to an 
ophthalmologist (patient 
at risk of developing 
proliferation)
Refer to an 
ophthalmologist (patient 
at risk of losing vision)
Refer to an 
ophthalmologist fairly 
urgently




occurring in or around 
the macula, and at 





























HVI: haemorrhages, venous beading; IRMA: intraretinal microvascular abnormalities; NPDR: nonproliferative retinopathy; PDR: proliferative retinopathy
Figure 1: Classification of diabetic retinopathy
Source: Division of Ophthalmology, University of Cape Town
Figure 2: Severe nonproliferative retinopathy
Source: Division of Ophthalmology, University of Cape Town
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•	 Reactivation, causing inflammation in the affected nerve, 
and resulting in corneal anaesthesia and neurotrophic 
keratitis. 
The risk of ocular involvement is increased in human 
immunodeficiency virus (HIV) infection, and also when there 
is involvement of the skin supplied by the external nasal 
nerve, a branch of the nasociliary nerve which supplies 
the tip, side and root of the nose. This is referred to as a 
positive Hutchinson’s sign, and correlates strongly with 
ocular involvement and increasing age. It occurs most 
frequently in the sixth and seventh decades of life. Signs 
and symptoms are often more severe in the elderly. Herpes 
zoster ophthalmicus tends to be more severe in patients 
with HIV. It can also be an early indicator of HIV infection.4,6 
A prodromal phase, lasting 3-5 days, precedes the 
appearance of the rash. It is characterised by malaise, fever 
and headaches. Some patients may experience burning 
or tingling in the affected dermatome. The rash is initially 
erythematous. Groups of vesicles develop within 24 hours, 
and become confluent over 2-4 days. Vesicles become 
pustular (Figure 8) before drying after 2-3 weeks. 
Treatment includes antiviral therapy with oral acyclovir 
800 mg five times daily for 7-10 days. This should be started 
when the patient first presents. This reduces the severity of 
the acute episode and the risk of post-herpetic neuralgia. 
Adequate analgesia should be prescribed to target the 
neurogenic pain. Amitryptilline or a similar agent should be 
Source: Division of Ophthalmology, University of Cape Town
Figure 4: New vessels on the iris
Source: Division of Ophthalmology, University of Cape Town
Figure 5: “Fresh” laser burns to the retina
Source: Division of Ophthalmology, University of Cape Town
Figure 6: New vessels on the retina or elsewhere with subhyaloid 
vitreous haemorrhage
Source: Division of Ophthalmology, University of Cape Town
Figure 7: Tractional complex causing striae over the macula
Source: Division of Ophthalmology, University of Cape Town
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used. Skin lesions should be treated with cool compresses 
and mechanical cleansing. Potassium permanganate dries 
the lesions well. Blepharitis or conjunctivitis can be treated 
with topical lubrication.7 Patients with shingles can transmit 
chickenpox. Therefore, contact with persons who are not 
immune, and those with immunodeficiency should be 
avoided until crusting of the lesions is complete.8
All patients with acute herpes zoster ophthalmicus and 
ocular involvement should be referred for ophthalmic 
evaluation. 
Human immunodeficiency virus microangiopathy
This is the most common fundus finding, and is found in 
more than half of patients with acquired immune deficiency 
syndrome (AIDS). It is characterised by cotton wool spots, 
retinal haemorrhages and capillary abnormalities. It is 
asymptomatic and temporary.2
Cytomegalovirus retinitis
Cytomegalovirus retinitis is a common ocular opportunistic 
infection in patients with AIDS. It occurs in patients with 
very low CD4 T-cell counts (below 50/mm3). Its incidence 
and rate of progression has declined since the advent of 
antiretroviral therapy. There are two types of retinitis. The 
indolent form affects the retinal periphery and progresses 
slowly. The fulminant type is characterised by a necrotising 
retinitis, accompanied by a vasculitis, giving a classic 
“pizza pie” appearance (Figure 9). It is treated with weekly 
injections of gancyclovir until the retinitis has regressed. 
Vision will not improve if the optic nerve or fovea is involved. 
Therefore, early referral within a week is advised.2
Ocular tumours
Ocular surface squamous neoplasia is a spectrum of 
benign, premalignant and malignant epithelial lesions of the 
conjunctiva and cornea. These lesions tend to be unilateral 
and resemble an atypical pterygium, which grows rapidly, 
becomes very raised (Figure 10) and keratinised. Besides 
HIV infection, some other risk factors for development 
include human papillomavirus type 16 infection and 
ultraviolet light exposure.2
Kaposi’s sarcoma presents on the lid and/or conjunctiva as 
a flat, bright-red lesion that may mimic a subconjunctival 
haemorrhage. It responds very well to radiotherapy. 
Molluscum contagiosum appears on eyelid skin (Figure 11), 
and can also cause conjunctivitis.2 It is treated by curettage 
of the lesions. 
Cranial nerve palsy
Intracranial infection or inflammation such as tuberculosis 
or Cryptococcus can often result in cranial nerve palsies. 
The optic nerve may be primarily or secondarily involved in 
central nervous system disease. Other cranial nerves that 
are often affected in HIV infection are the oculomotor (III), 
trochlear (IV), abducens (VI) and facial (VII) nerves.2 
Thyroid eye disease 
Thyroid eye disease affects 25-50% of patients with 
Grave’s disease, of which 5% have severe involvement. 
It may precede, coincide with or follow hyperthyroidism, 
and usually bears no relationship to the severity of thyroid 
Source: Division of Ophthalmology, University of Cape Town
Figure 9: Necrotic retina with vasculitis due to cytomegalovirus 
retinitis
Source: Division of Ophthalmology, University of Cape Town
Figure 10: Squamous carcinoma of the conjunctiva
Source: Division of Ophthalmology, University of Cape Town
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dysfunction. The major clinical risk factor for developing 
thyroid eye disease is smoking. The greater the number of 
cigarettes smoked per day, the greater the risk. Conversely, 
giving up smoking reduces the risk. Women are five times 
more likely to be affected by thyroid eye disease than men. 
Radioactive iodine, used to treat hyperthyroidism, can 
worsen thyroid eye disease.4
The pathogenesis involves an organ-specific autoimmune 
reaction which produces inflammation of the extraocular 
muscles and inflammatory cellular infiltration of the orbital 
tissues (soft tissue, and fat and lacrimal glands). Clinical 
manifestations include soft tissue involvement, lid retraction, 
proptosis (Figure 12), optic neuropathy and restrictive 
myopathy.4 There are two stages in the development of the 
disease viz. a congestive (inflammatory) stage in which the 
eyes are red and painful (tends to remit within three years 
and only 10% develop serious long-term ocular problems); 
and a fibrotic (quiescent) stage in which the eyes are not 
inflamed, but may have a painless motility defect. 
The European Group on Graves’ Ophthalmopathy 
(EUGOGO) severity classification of thyroid eye disease is 
as follows.9
Mild disease
Mild disease has a minor impact on daily life and is insufficient 
to justify immunosuppressive or surgical treatment. 
This group is characterised by:
•	 Mild soft tissue involvement.
•	 Mild lid retraction < 2 mm.
•	 Proptosis < 3 mm.
•	 No diplopia, nor optic neuropathy, nor signs of corneal 
exposure.
Moderate to severe disease 
Moderate to severe disease is non-sight threatening, but has 
sufficient impact on daily life to justify immunosuppressive 
therapy. 
It is characterised by:
•	 Moderate to severe soft tissue involvement.
•	 Lid retraction > 2 mm.
•	 Proptosis > 3 mm.
•	 Diplopia.
Severe disease
Severe disease includes optic neuropathy and/or corneal 
breakdown.
Management depends on the severity of disease and is 
often controversial. EUGOGO suggests the following:
•	 Mild disease: Lubricants must be used. Elevate the head 
of the bed, use ice packs and give selenium 200 µg/day 
(an antioxidant is needed for conversion of T4 to T3).10 
•	 Moderate disease: Immunosuppressive therapy should 
be employed, using a systemic steroid for 6-12 weeks 
(radiotherapy may be included).
•	 Severe disease (sight threatening): A systemic steroid, 
followed by orbital decompression if there is no 
improvement having taken the steroid.
Cosmetic surgery to the orbit, eyelids and muscles can be 
considered once the disease is in the quiescent phase.
Syphilis
Syphilis is regarded as “the great mimicker” and has been 
implicated in a variety of ocular pathologies. It has been 
associated with chancre of the lid, interstitial keratitis, uveitis 
and chorioretinitis (Figure 13), as well as optic neuritis and 
optic atrophy. The eye is considered to be part of the brain, 
and thus syphilis inside the eye is treated as neurosyphilis 
with intravenous penicillin for 10 days.2 A lumbar puncture 
should also be performed to confirm the diagnosis. 
Collagen vascular diseases
Diseases such as rheumatoid arthritis, systemic lupus 
erythematosis, Wegener’s granulomatosis and other 
vasculitic disorders can cause various forms of ocular 
inflammation. These diseases can be associated with 
scleritis (Figure 14), episcleritis and immune-mediated 
Source: Division of Ophthalmology, University of Cape Town
Figure 12: Proptosis (exophthalmos) in a patient with Grave’s disease
Source: Division of Ophthalmology, University of Cape Town
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keratitis. Management involves treating the systemic 
disease and referral for immunosuppressive therapy for the 
ocular condition.
Seronegative spondyloarthropathies 
Rheumatoid factor-negative and human leukocyte antigen 
B27-positive conditions, such as ankylosing spondylitis, 
Reiter’s syndrome and psoriasis, are often associated with 
a chronic, relapsing nongranulomatous uveitis, which can 
be severe. These patients should be referred for ophthalmic 
management as they often require intensive topical steroid 
therapy and careful follow-up. 
Skin disease
Atopic conditions, such as eczema, are associated with 
atopic (allergic) conjunctivitis, cataracts, keratoconus 
and poor resistance to herpes simplex infection. Minor 
complaints can be treated symptomatically, but referral is 
indicated if vision is reduced. Stevens-Johnson syndrome 
and pemphigoid can destroy conjunctival goblet cells and 
lacrimal gland orifices, resulting in a very dry ocular surface 
and corneal scarring.2 These patients require intensive 
lubrication in the acute phase, as well as early referral for 
ophthalmic management. 
Systemic diseases where eye findings may help with 
the diagnosis
Many potentially life-threatening systemic illnesses have 
accompanying ocular signs which may help with the 
diagnosis (Table II). Rapid blood pressure reduction can 
result in ischaemic optic neuropathy in patients with 
malignant hypertension. Therefore, it is important to reduce 
blood pressure gradually during treatment.2 Arcus cornealis 
(Figure 15) and xanthelasma in a younger patient can alert 
the clinician to hypercholesterolaemia and lead to early 
initiation of systemic therapy.
Drugs and the eye
Table III lists the important systemic drugs with ocular side-
effects and vice versa.
Conclusion
Systemic diseases like diabetes, herpes zoster ophthalmicus 
and thyroid ophthalmopathy often have ocular involvement, 
and if eye signs are not detected early, the visual 
consequences can be devastating. Diabetic retinopathy 
is the third leading cause of blindness in this country.2 
Therefore, it is important for the primary care physician 
to be familiar with the spectrum of ocular involvement in 
the systemic diseases that have been covered in this 
manuscript since appropriate intervention can be sight 
saving for the patient. 
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Figure 15: Arcus cornealis secondary to hypercholesterolaemia
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